Skip to main content
SpringerLink
Log in

Seltene Indikationen für intravenöse Immunglobuline in der klinischen Neurologie

  • Chapter
Immunglobuline in der klinischen Neurologie

  • 91 Accesses

Zusammenfassung

Bei einer Reihe von neurologischen Erkrankungen, bei denen eine Auto-immunpathogenese belegt ist oder vermutet wird, wurden IVIg versuchsweise eingesetzt Für alle hier kurz zusammengefassten Darstellungen gilt, dass es sich jeweils nur um kleine offene Serien oder aber um Einzelfallbeobachtungen handelt. Eine gesicherte Indikation für den Einsatz von IVIg stellt keines der hier besprochenen Krankheitsbilder dar.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Antonelli A, Saracino A, Alberti B, Canapicchi R, Cartei F, Lepri A, Laddaga M, Baschieri L (1992) High-dose intravenous immunoglobulin treatment in Graves ophthalmopathy. Acta Endocrinol 126:13–23

    Article  PubMed  CAS  Google Scholar 

  2. Berlit P (1988) Prognosis and long term course of viral encephalitis. J Neuroim-munol 20:117–125

    Article  CAS  Google Scholar 

  3. Berlit P (1989) Immunoglobulin therapy in neurologic diseases. Klin Wochenschr 67:967–970

    Article  PubMed  CAS  Google Scholar 

  4. Bradley WG, Chad D, Verghese JP, Liu HC, Good P, Gabbai AA, Adelman LS (1984) Painful lumbosacral plexopathy with elevated erythrocyte sedimentation rate: a treatable inflammatory syndrome. Ann Neurol 15:457–464

    Article  PubMed  CAS  Google Scholar 

  5. Dalakas MC, Stein DP, Otero C, Sekul E, Cupler EJ, McCrosky S (1994) Effect of highdose intravenous immunoglobulin (IVIg) on amyotrophic lateral sclerosis and multifocal motor neuropathy. Arch Neurol 51:861–864

    Article  PubMed  CAS  Google Scholar 

  6. Dalakas MC (1999) Intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: present status and practical therapeutic guidelines. Muscle Nerve 22:1479–1497

    Article  PubMed  CAS  Google Scholar 

  7. Duse M, Notarangelo LD, Tiberti S, Menegati E, Plebani A, Ugazio AG (1996) Intravenous immunoglobulin in the treatment of intractable childhood epilepsy. Clin Exp Immunol 104:71–76

    PubMed  Google Scholar 

  8. Dwyer JM (1992) Manipulating the immune system with immune globulin. N Engl J Med 326:107–115

    Article  PubMed  CAS  Google Scholar 

  9. Dwyer JM, Benson EM, Currie JN, O’Day J (1991) Intravenously administered IgG for the treatment of thyroid eye disease. In: Imbach P (ed) Immunotherapy with intravenous immunoglobulins. Academic Press, London, pp 387–394

    Google Scholar 

  10. Fox RJ, Kasner SE, Galetta SL, Chalela JA (2000) Treatment of Bickerstaff’s brainstem encephalitis with immune globulin. J Neurol Sci 178:88–90

    Article  PubMed  CAS  Google Scholar 

  11. Gross-Tsur V, Shaley RS, Kazir E, Engelhard D, Amir N (1993) Intravenous high-dose gammaglobulins for intractable childhood epilepsy. Acta Neurol Scand 88:204–209

    Article  PubMed  CAS  Google Scholar 

  12. Höllinger P, Sturzenegger M (2000) Chronic progressive primary lumbosacral plexus neuritis: MRI findings and response to immunoglobulin therapy. J Neurol 247:143–145

    Article  PubMed  Google Scholar 

  13. Ilium N, Taudorf K, Heilmann C, Smith T, Wulff K, Mansa B, et al (1990) Intravenous immunoglobulin: a single-blind trial in children with Lennox-Gastaut syndrome. Neuropediatrics 21:87–90

    Article  Google Scholar 

  14. Krendel DA, Costigan DA, Hopkins LC (1995) Successful treatment of neuropathies in patients with diabetes mellitus. Arch Neurol 52:1053–1061

    Article  PubMed  CAS  Google Scholar 

  15. Mohr M, Englisch L, Roth A, Burchardi H, Zielmann S (1997) Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis. Intensive Care Med 23:1144–1149

    Article  PubMed  CAS  Google Scholar 

  16. Otten A, Vermeulen M, Bossuyt PMM (1995) Intravenous Immunglobulin treatment in neurological diseases. J Neurol Neurosurg Psychiat 59:359–361

    Article  Google Scholar 

  17. Sahlas DJ, Miller SP, Guerin M, Veilleux M, Grancis G (2000) Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin. Neurology 54:1370–1372

    PubMed  CAS  Google Scholar 

  18. Siber GR (1992) Immune globulin to prevent nosocomial infections. N Engl J Med 327:269–271

    Article  PubMed  CAS  Google Scholar 

  19. Triggs WJ, Young MS, Eskin T, Valenstein E (1997) Treatment of idiopathic lumbosacral plexopathy with intravenous immunoglobulin. Muscle Nerve 20:244–246

    Article  PubMed  CAS  Google Scholar 

  20. van Engelen BG, Renier WO, Weemaes CM, Gabreels FJ, Meinardi H (1994) Immunoglobulin treatment in epilepsy, a review of the literature. Epilepsy Res 19:181–190

    Article  PubMed  Google Scholar 

  21. van Engelen BG, Renier WO, Weemaes CM, Strengers PF, Bernsen PJ, Notermans SL (1994) High-dose intravenous immunoglobulin treatment in cryptogenic West and Lennox-Gastaut syndrome, an add-on study. Eur J Pediatr 153:762–769

    Article  PubMed  Google Scholar 

  22. van Rijckevorsel-Harmant K, Delire M, Schmitz-Moorman W, Wieser HG (1994) Treatment of refractory epilepsy with transvenous immunoglobulins. Results of the first double-blind/dose finding clinical study. Int J Clin Lab Res 24:162–166

    Article  PubMed  Google Scholar 

  23. Verma A, Bradley WG (1994) High-dose intravenous immunoglobulin therapy in chronic progressive lumbosacral plexopathy. Neurology 44:248–260

    PubMed  CAS  Google Scholar 

  24. Wijdicks EF, Fulgham JR (1994) Failure of high dose intravenous immunoglobulins to alter the clinical course of critical illness polyneuropathy. Muscle Nerve 17:1494–1495

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. P. Berlit
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Neurologische Klinik mit Klinischer Neurophysiologie, Alfried Krupp Krankenhaus, Alfried-Krupp-Straße 21, 45117, Essen, Deutschland

    Peter Berlit

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Steinkopff Verlag Darmstadt

About this chapter

Cite this chapter

Berlit, P. (2001). Seltene Indikationen für intravenöse Immunglobuline in der klinischen Neurologie. In: Berlit, P. (eds) Immunglobuline in der klinischen Neurologie. Steinkopff. https://doi.org/10.1007/978-3-642-93716-3_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-93716-3_14

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-642-93717-0

  • Online ISBN: 978-3-642-93716-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation